Register
Login:
Share:
Email Facebook Twitter

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018 Watch here

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money'


Regulatory News


Notice of Results

Fri, 10th Nov 2017 07:00


RNS Number : 1079W
Brewin Dolphin Holdings PLC
10 November 2017
 

 

 

10 November 2017

 

 

 

Brewin Dolphin Holdings PLC

("Brewin Dolphin")

 

Notice of Preliminary Results

 

 

Brewin Dolphin will be announcing its preliminary results for the financial year ended 30 September 2017 on Wednesday 29 November 2017.

 

There will be an analyst presentation at 9:00am.

 

For further information contact:

 

FTI Consulting

David Waller: +44 (0) 203 727 1651

Edward Berry: +44 (0) 203 727 1046

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORDMMGMNLDGNZM





Back to Regulatory News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.